ARMP Armata Pharmaceuticals, Inc.
$5.38▲ +2.87%
Healthcare
Other
After hours
$5.38▼ -0.19%
Sep 11, 4:01 PM ET
Volume 43.6K
Avg Volume (10D) 76.6K
Key Metrics & Fundamentals
Market Cap
$200.04M
P/E Ratio
–
Div Yield
–%
52W Range
2.86 - 16.34
% vs 50 MA
9.08%
% vs 200 MA
-28.03%
RSI-14
52.0
MACD Histogram
+0.0200
Beta (1Y vs SPY)
0.15
Free Cash Flow
-$5.85M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$109.33M
COGS
–
Operating Exp
$8.79M
Operating Income
-$8.79M
EBIT
-$8.79M
Pretax Income
-$115.35M
Net Income
-$115.35M
EPS (Diluted)
-3.16
Price & Volume History
Loading chart…
Recent News
Armata Pharmaceuticals to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
PR Newswire · Sep 10, 2026 11:00 AM
Armata Pharmaceuticals Announces New Publication That Advances Understanding of Phage Biology to Support Development of Next-Generation Antibacterials
PR Newswire · Sep 3, 2026 11:00 AM
Bronchiectasis Market is Expected to Surge at a CAGR of 15% by 2036, Owing to the Launch of DPP1/CatC Inhibitors, Therapeutic Phage Cocktails, Nebulized Mucoactive Agents, and Other Novel Mechanisms | DelveInsight
PR Newswire · Aug 13, 2026 2:31 PM
Armata Pharmaceuticals Announces Financial Results for the Second Quarter 2026 and Provides a Corporate Update
PR Newswire · Aug 12, 2026 8:05 PM
Armata Pharmaceuticals (ARMP) Stock Jumps 12.2%: Will It Continue to Soar?
Zacks · Jul 21, 2026 11:05 AM
Armata Pharmaceuticals Names David House as CFO; Advances Staphylococcus Aureus Treatment Candidate
MT Newswires · Jul 20, 2026 12:51 PM
Armata Pharmaceuticals Achieves Key Progress Across Clinical, Regulatory and Manufacturing Activities Supporting Planned Phase 3 Initiation of AP-SA02
PR Newswire · Jul 20, 2026 11:00 AM
Armata Pharma Reaches FDA Agreement on Pediatric Study Plan for AP-SA02
MT Newswires · Jul 13, 2026 11:47 AM
Armata Pharmaceuticals Receives Agreement from FDA on Initial Pediatric Study Plan for AP-SA02 for the Treatment of Complicated Staphylococcus aureus Bacteremia
PR Newswire · Jul 13, 2026 11:00 AM
Sector Update: Healthcare Stocks Mixed Pre-Bell Tuesday
MT Newswires · Jun 23, 2026 1:14 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See ARMP's money flow as a full page
Social Sentiment
No Reddit posts found for ARMP.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.